SCHEMBL3316204

SCHEMBL3316204

C=CCN1c2ccc(N(C)S(=O)(=O)c3ccccc3)cc2C2CN(C3CCOCC3)CCC21

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.37
GAA P10253 1/20 0.37
APOBEC3A P31941 1/20 0.37
APOBEC3G Q9HC16 1/20 0.37
ALDH1A1 P00352 2/20 0.35
USP30 Q70CQ3 1/20 0.33
CYP2C9 P11712 1/20 0.33
HPGD P15428 1/20 0.33
SIGMAR1 Q99720 1/20 0.32
NR1I2 O75469 1/20 0.31
KMT2A Q03164 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
CNR2 P34972 1/20 0.31
KEAP1 Q14145 1/20 0.31
NFE2L2 Q16236 1/20 0.31
LMNA P02545 1/20 0.30
HTT P42858 1/20 0.30
RECQL P46063 1/20 0.30
ATM Q13315 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3314305 0.93 GAA (0.38) MAPTGAAAPOBEC3AAPOBEC3GALDH1A1
SCHEMBL3306190 0.88 MAPT (0.41) MAPTGAAAPOBEC3AAPOBEC3GALDH1A1
SCHEMBL3314883 0.83 PTGDR2 (0.42) MAPTGAAALDH1A1HPGDKMT2A
SCHEMBL3310313 0.79 GAA (0.34) GAAAPOBEC3AAPOBEC3GCNR1
SCHEMBL3312357 0.78 CCR5 (0.39) MAPTGAAAPOBEC3AAPOBEC3GUSP30
SCHEMBL3309907 0.78 DRD2 (0.38) MAPTGAAAPOBEC3AAPOBEC3GALDH1A1
SCHEMBL3316176 0.78 GAA (0.32) MAPTGAASMN1; SMN2CNR1
SCHEMBL3313158 0.76 ALDH1A1 (0.42) MAPTALDH1A1KMT2ASMN1; SMN2LMNA
SCHEMBL13329679 0.71 CNR1 (0.58) CNR2CNR1
SCHEMBL13329678 0.65 CNR1 (0.57) CNR2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100113502-A1 Novel Tetrahydro-1H-Pyrido[4,3-b] Indole Derivatives as CB1 Receptor Ligands ASTRAZENECA AB (SE) 2010-05-06 US disclosed
EP-1863810-A1 NOVEL TETRAHYDRO-1H-PYRIDO [4,3-b] INDOLE DERIVATIVES AS CB1' RECEPTOR LIGANDS AstraZeneca AB (SE) 2007-12-12 EP disclosed
WO-2006101434-A1 NOVEL TETRAHYDRO-1H-PYRIDO [4,3-b] INDOLE DERIVATIVES AS CB1’ RECEPTOR LIGANDS ASTRAZENECA AB (SE) 2006-09-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100113502-A1 Novel Tetrahydro-1H-Pyrido[4,3-b] Indole Derivatives as CB1 Receptor Ligands CNR1, CNR2, OPRL1 MAPT 2193/4885GAA 4876/4885APOBEC3A 4223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.